vs

Side-by-side financial comparison of BRC Inc. (BRCC) and Oncology Institute, Inc. (TOI). Click either name above to swap in a different company.

Oncology Institute, Inc. is the larger business by last-quarter revenue ($142.0M vs $112.7M, roughly 1.3× BRC Inc.). BRC Inc. runs the higher net margin — -2.8% vs -5.3%, a 2.4% gap on every dollar of revenue. On growth, Oncology Institute, Inc. posted the faster year-over-year revenue change (41.6% vs 6.5%). Oncology Institute, Inc. produced more free cash flow last quarter ($2.2M vs $-9.4M). Over the past eight quarters, Oncology Institute, Inc.'s revenue compounded faster (22.5% CAGR vs 7.0%).

BRC Inc., operating under the Black Rifle Coffee brand, is a U.S.-headquartered premium coffee and lifestyle brand. It sells roasted coffee beans, ready-to-drink coffee products, branded apparel, and outdoor gear, targeting primarily veteran, first responder, and outdoor enthusiast consumer segments across North America, via both e-commerce and physical retail channels.

Oncology Institute, Inc. is a specialized healthcare enterprise focused on delivering patient-centric, evidence-based oncology care services, including advanced treatment regimens, clinical trial access, and supportive care programs. It primarily operates across the United States, serving patients with diverse cancer diagnoses and partnering with care teams to improve treatment outcomes.

BRCC vs TOI — Head-to-Head

Bigger by revenue
TOI
TOI
1.3× larger
TOI
$142.0M
$112.7M
BRCC
Growing faster (revenue YoY)
TOI
TOI
+35.1% gap
TOI
41.6%
6.5%
BRCC
Higher net margin
BRCC
BRCC
2.4% more per $
BRCC
-2.8%
-5.3%
TOI
More free cash flow
TOI
TOI
$11.6M more FCF
TOI
$2.2M
$-9.4M
BRCC
Faster 2-yr revenue CAGR
TOI
TOI
Annualised
TOI
22.5%
7.0%
BRCC

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
BRCC
BRCC
TOI
TOI
Revenue
$112.7M
$142.0M
Net Profit
$-3.2M
$-7.5M
Gross Margin
32.1%
Operating Margin
-6.3%
-4.9%
Net Margin
-2.8%
-5.3%
Revenue YoY
6.5%
41.6%
Net Profit YoY
-29.3%
43.0%
EPS (diluted)
$-0.02
$-0.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BRCC
BRCC
TOI
TOI
Q4 25
$112.7M
$142.0M
Q3 25
$100.7M
$136.6M
Q2 25
$94.8M
$119.8M
Q1 25
$90.0M
$104.4M
Q4 24
$105.9M
$100.3M
Q3 24
$98.2M
$99.9M
Q2 24
$89.0M
$98.6M
Q1 24
$98.4M
$94.7M
Net Profit
BRCC
BRCC
TOI
TOI
Q4 25
$-3.2M
$-7.5M
Q3 25
$-486.0K
$-16.5M
Q2 25
$-5.3M
$-17.0M
Q1 25
$-2.9M
$-19.6M
Q4 24
$-2.5M
$-13.2M
Q3 24
$-535.0K
$-16.1M
Q2 24
$-482.0K
$-15.5M
Q1 24
$548.0K
$-19.9M
Gross Margin
BRCC
BRCC
TOI
TOI
Q4 25
32.1%
Q3 25
36.9%
Q2 25
33.9%
Q1 25
36.1%
Q4 24
38.1%
Q3 24
42.1%
Q2 24
41.9%
Q1 24
42.9%
Operating Margin
BRCC
BRCC
TOI
TOI
Q4 25
-6.3%
-4.9%
Q3 25
0.5%
-5.9%
Q2 25
-13.3%
-9.4%
Q1 25
-6.0%
-9.5%
Q4 24
-2.1%
-11.9%
Q3 24
1.1%
-13.9%
Q2 24
1.1%
-16.6%
Q1 24
4.0%
-19.0%
Net Margin
BRCC
BRCC
TOI
TOI
Q4 25
-2.8%
-5.3%
Q3 25
-0.5%
-12.1%
Q2 25
-5.6%
-14.2%
Q1 25
-3.2%
-18.8%
Q4 24
-2.3%
-13.1%
Q3 24
-0.5%
-16.1%
Q2 24
-0.5%
-15.7%
Q1 24
0.6%
-21.0%
EPS (diluted)
BRCC
BRCC
TOI
TOI
Q4 25
$-0.02
$-0.04
Q3 25
$0.00
$-0.14
Q2 25
$-0.07
$-0.15
Q1 25
$-0.04
$-0.21
Q4 24
$-0.03
$-0.14
Q3 24
$-0.01
$-0.18
Q2 24
$-0.01
$-0.17
Q1 24
$0.01
$-0.22

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BRCC
BRCC
TOI
TOI
Cash + ST InvestmentsLiquidity on hand
$4.3M
Total DebtLower is stronger
$34.7M
Stockholders' EquityBook value
$45.7M
$-15.7M
Total Assets
$209.2M
$164.7M
Debt / EquityLower = less leverage
0.76×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BRCC
BRCC
TOI
TOI
Q4 25
$4.3M
Q3 25
$9.5M
Q2 25
$4.3M
Q1 25
$3.9M
Q4 24
$6.8M
Q3 24
$7.3M
Q2 24
$9.6M
$9.9M
Q1 24
$4.0M
$29.8M
Total Debt
BRCC
BRCC
TOI
TOI
Q4 25
$34.7M
Q3 25
$35.0M
Q2 25
$72.7M
Q1 25
$68.8M
Q4 24
$65.1M
Q3 24
$64.9M
Q2 24
$66.5M
Q1 24
$61.5M
Stockholders' Equity
BRCC
BRCC
TOI
TOI
Q4 25
$45.7M
$-15.7M
Q3 25
$48.0M
$-12.3M
Q2 25
$10.1M
$-9.0M
Q1 25
$11.2M
$5.1M
Q4 24
$13.2M
$3.6M
Q3 24
$14.5M
$15.5M
Q2 24
$14.9M
$29.2M
Q1 24
$14.6M
$41.3M
Total Assets
BRCC
BRCC
TOI
TOI
Q4 25
$209.2M
$164.7M
Q3 25
$222.4M
$163.6M
Q2 25
$225.3M
$159.8M
Q1 25
$222.9M
$164.0M
Q4 24
$227.4M
$172.7M
Q3 24
$233.7M
$179.2M
Q2 24
$229.9M
$179.6M
Q1 24
$227.2M
$204.5M
Debt / Equity
BRCC
BRCC
TOI
TOI
Q4 25
0.76×
Q3 25
0.73×
Q2 25
7.19×
Q1 25
6.15×
Q4 24
4.94×
Q3 24
4.47×
Q2 24
4.46×
Q1 24
4.21×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BRCC
BRCC
TOI
TOI
Operating Cash FlowLast quarter
$-8.7M
$3.2M
Free Cash FlowOCF − Capex
$-9.4M
$2.2M
FCF MarginFCF / Revenue
-8.3%
1.5%
Capex IntensityCapex / Revenue
0.6%
0.7%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-13.5M
$-27.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BRCC
BRCC
TOI
TOI
Q4 25
$-8.7M
$3.2M
Q3 25
$6.4M
$-12.6M
Q2 25
$-3.3M
$-10.2M
Q1 25
$-4.1M
$-5.0M
Q4 24
$2.2M
$4.2M
Q3 24
$1.9M
$819.0K
Q2 24
$2.3M
$-15.7M
Q1 24
$4.9M
$-15.9M
Free Cash Flow
BRCC
BRCC
TOI
TOI
Q4 25
$-9.4M
$2.2M
Q3 25
$5.6M
$-13.2M
Q2 25
$-4.3M
$-11.4M
Q1 25
$-5.3M
$-5.3M
Q4 24
$504.0K
$2.4M
Q3 24
$-205.0K
$417.0K
Q2 24
$147.0K
$-17.5M
Q1 24
$2.2M
$-16.5M
FCF Margin
BRCC
BRCC
TOI
TOI
Q4 25
-8.3%
1.5%
Q3 25
5.5%
-9.7%
Q2 25
-4.5%
-9.5%
Q1 25
-5.9%
-5.1%
Q4 24
0.5%
2.4%
Q3 24
-0.2%
0.4%
Q2 24
0.2%
-17.7%
Q1 24
2.2%
-17.4%
Capex Intensity
BRCC
BRCC
TOI
TOI
Q4 25
0.6%
0.7%
Q3 25
0.8%
0.4%
Q2 25
1.0%
1.0%
Q1 25
1.3%
0.3%
Q4 24
1.6%
1.8%
Q3 24
2.2%
0.4%
Q2 24
2.4%
1.9%
Q1 24
2.8%
0.6%
Cash Conversion
BRCC
BRCC
TOI
TOI
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
8.97×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BRCC
BRCC

Sales Channel Through Intermediary$72.9M65%
Sales Channel Directly To Consumer$34.4M31%
Outpost$5.4M5%

TOI
TOI

Other$82.1M58%
Fee For Service$36.3M26%
Capitated Revenue$23.6M17%

Related Comparisons